Hamdan Almalky

Dr. Hamdan Almalky

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
FOUAD DAMIRIFOUAD DAMIRI
FOUAD DAMIRI
Nagavendra KommineniNagavendra Kommineni
Nagavendra Kommineni
SESamuel Ogbeide Ebhodaghe
Samuel Ogbeide Ebhodaghe
RBRaviteja Bulusu
Raviteja Bulusu
GVGeetha Satya Sainaga Jyothi Vaskuri
Geetha Satya Sainaga Jyothi Vaskuri
MBMOHAMMED BERRADA
MOHAMMED BERRADA
In this focused progress review, the most widely accepted methods of transdermal drug delivery are hypodermic needles, transdermal patches and topical creams. However, microneedles (MNs) (or microneedle arrays) are low-invasive 3D biomedical constructs that bypass the skin barrier and produce systemic and localized pharmacological effects. In the past, biomaterials such as carbohydrates, due to their physicochemical properties, have been extensively used to manufacture microneedles (MNs). Due to their wide range of functional groups, carbohydrates enable the design and development of tunable properties and functionalities. In recent years, numerous microneedle products have emerged on the market, although much research needs to be undertaken to overcome the various challenges before the successful introduction of microneedles into the market. As a result, carbohydrate-based microarrays have a high potential to achieve a future step in sensing, drug delivery, and biologics restitution. In this review, a comprehensive overview of carbohydrates such as hyaluronic acid, chitin, chitosan, chondroitin sulfate, cellulose and starch is discussed systematically. It also discusses the various drug delivery strategies and mechanical properties of biomaterial-based MNs, the progress made so far in the clinical translation of carbohydrate-based MNs, and the promotional opportunities for their commercialization. In conclusion, the article summarizes the future perspectives of carbohydrate-based MNs, which are considered as the new class of topical drug delivery systems.

27 January 2022 in Molecules
Verified
Journal Article
Open access
PDF file
AGAnju Goyal
Anju Goyal
ASAditya Sharma
Aditya Sharma
JKJasanpreet Kaur
Jasanpreet Kaur
SKSAPNA KUMARI
SAPNA KUMARI
MGMadhukar Garg
Madhukar Garg
Mohamed Abdel-DaimMohamed Abdel-Daim
Mohamed Abdel-Daim
Cosmetic-containing herbals are a cosmetic that has or is claimed to have medicinal properties, with bioactive ingredients purported to have medical benefits. There are no legal requirements to prove that these products live up to their claims. The name is a combination of “cosmetics” and “pharmaceuticals”. “Nutricosmetics” are related dietary supplements or food or beverage products with additives that are marketed as having medical benefits that affect appearance. Cosmetic-containing herbals are topical cosmetic–pharmaceutical hybrids intended to enhance the health and beauty of the skin. Cosmetic-containing herbals improve appearance by delivering essential nutrients to the skin. Several herbal products, such as cosmetic-containing herbals, are available. The present review highlights the use of natural products in cosmetic-containing herbals, as natural products have many curative effects as well as healing effects on skin and hair growth with minimal to no side effects. A brief description is given on such plants, their used parts, active ingredients, and the therapeutic properties associated with them. Mainly, the utilization of phytoconstituents as cosmetic-containing herbals in the care of skin and hair, such as dryness of skin, acne, eczema, inflammation of the skin, aging, hair growth, and dandruff, along with natural ingredients, such as for hair colorant, are explained in detail in the present review.

23 February 2022 in Materials
Verified
Journal Article
Open access
PDF file
FOUAD DAMIRIFOUAD DAMIRI
FOUAD DAMIRI
HRHabibur Rahman
Habibur Rahman
MZMehrukh Zehravi
Mehrukh Zehravi
AAAeshah Ali Awaji
Aeshah Ali Awaji
MNMohammed Z. Nasrullah
Mohammed Z. Nasrullah
MBMOHAMMED BERRADA
MOHAMMED BERRADA
Polymeric nanocomposites have been outstanding functional materials and have garnered immense attention as sustainable materials to address multi-disciplinary problems. MXenes have emerged as a newer class of 2D materials that produce metallic conductivity upon interaction with hydrophilic species, and their delamination affords monolayer nanoplatelets of a thickness of about one nm and a side size in the micrometer range. Delaminated MXene has a high aspect ratio, making it an alluring nanofiller for multifunctional polymer nanocomposites. Herein, we have classified and discussed the structure, properties and application of major polysaccharide-based electroactive hydrogels (hyaluronic acid (HA), alginate sodium (SA), chitosan (CS) and cellulose) in biomedical applications, starting with the brief historical account of MXene’s development followed by successive discussions on the synthesis methods, structures and properties of nanocomposites encompassing polysaccharides and MXenes, including their biomedical applications, cytotoxicity and biocompatibility aspects. Finally, the MXenes and their utility in the biomedical arena is deliberated with an eye on potential opportunities and challenges anticipated for them in the future, thus promoting their multifaceted applications.

24 July 2019 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
HAHamdan Almalky
Hamdan Almalky
AOAbdel Moneim Osman
Abdel Moneim Osman
ZDZoheir Damanhouri
Zoheir Damanhouri
HAHuda Alkreathy
Huda Alkreathy
JAJumana Al-Aama
Jumana Al-Aama
HMHadiah Al Mahdi
Hadiah Al Mahdi
Doxorubicin (DOX) is one of the most important anticancer agents used in treating breast cancer. However, chronic cardiotoxicity and multidrug resistance limit the chemotherapeutic use of DOX. This study aimed to evaluate the capability of calcium channel blocker diltiazem (DIL) to reverse DOX resistance in breast cancer MCF-7 cells and to confer protection against DOX-induced cardiotoxicity in Wistar rats. For this purpose, we explored the effects of DOX on cell cycle phase distribution and expression of ABCB1, FOXO3a, and p53 genes in the presence and absence of DIL (20 μg/ml) and studied the ability of DIL to prevent DOX-induced cardiotoxicity after a single injection of DOX (15 mg/kg) in male Wister rats. We found that compared with DOX alone treatment, DIL + DOX treatment down regulated the ABCB1 gene expression by > fourfold but up regulated the FOXO3a and p53 genes expression by 1.5 fold. DIL treatment conferred protection against DOX-induced cardiotoxicity, as indicated by a decrease in the levels of the cardiac enzyme creatine kinase MB and malondialdehyde and an increase in the total antioxidant capacity and glutathione peroxidase levels. These biochemical results were further confirmed by the histopathological investigation of cardiac cells, which showed normal cardiac cells with central vesicular nuclei and prevention of DOX-induced disruption of normal cardiac architecture in the DIL to DOX group. Taken together, our results indicate that DIL treatment can reverse the resistance of breast cancer cells to the therapeutic effects of DOX and can protect against DOX-induced cardiotoxicity in rats.

1 December 2019 in Breast Cancer Management
Verified
Journal Article
Open access
HAHamdan Almalky
Hamdan Almalky
ZDZoheir A Damanhouri
Zoheir A Damanhouri
JAJumana Y Al Aama
Jumana Y Al Aama
AQAli A Al Qahtani
Ali A Al Qahtani
WRWafaa S Ramadan
Wafaa S Ramadan
AOAbdel-Moneim M Osman
Abdel-Moneim M Osman

6 January 2020 in International Journal of Research in Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
HAHamdan Almalky
Hamdan Almalky
The occurrence of withdrawal symptoms is regarded as the key to mediating smoking relapse amongst smokers. The present study acknowledged the high relapse rates emerging from the inability to address the causes of powerful addiction effects besides identifying chronic disorders caused by nicotine. The present study explored nicotine addiction and its effects on different smoking patterns to provide an informative platform to design interventions that would deliver effective ways of quitting smoking. The study utilized systemic reviews on publications of previous studies obtained from scholarly journal databases, including PubMed, Medline, EBSCO Host, Google Scholar, and Cochrane. Moreover, the study used secondary information obtained from health organizations using filters and keywords to retrieve relevant information. The use of search keywords and filters limited the study to relevant peer-reviewed journals. The study utilized information retrieved from 35 studies obtained from peer-reviewed journals on “nicotine dependence,” “smoking cessation,” and “pharmacology of nicotine dependence and addiction.” The drug tolerance arising in nicotine dependence involved minimized tolerance often occurring during recurrent administration of drugs translated to neuroadaptation. The brain tends to develop challenges in the absence of nicotine, particularly when individuals quit smoking, thus compelling them to backslide from their abstinence. Higher nicotine dependence demotivates individuals from quitting smoking, making the cessation interventions unfruitful, worsened by the inability to understand the causative factors. The solution to overcome nicotine dependence alongside tobacco usage involves a complex treatment technique that would aim to reduce the probability of relapse. Nicotine dependence, Nicotine addiction, Tobacco addiction cycle, Neural survival, Pharmacology of nicotine